According to Fortune Business Insights, the global digital pathology market size was valued at USD 1.30 billion in 2025 and is projected to grow from USD 1.47 billion in 2026 to USD 5.75 billion by 2034, exhibiting a CAGR of 18.56% during the forecast period from 2026 to 2034. North America held the leading position with a 36.74% market share in 2025.
The strong projected growth reflects increasing digitization across pathology workflows, rising adoption of advanced diagnostic technologies, and the growing need to manage higher pathology workloads efficiently.
Market Overview
Digital pathology provides a digital alternative to conventional pathology workflows by converting pathology slides into digital formats that can be analyzed and accessed electronically. The technology can support remote reviewing, image analysis, workflow management, data storage, and high-throughput applications.
The COVID-19 pandemic accelerated the digitization of pathology systems. The market recorded a growth rate of 31.2% in 2020, compared with 11.6% in 2019, as social distancing measures reduced in-person consultations and encouraged the adoption of remote pathology solutions. Regulatory actions also supported adoption, including a U.S. FDA policy introduced in April 2020 that expanded the availability of digital pathology devices for remote review and reporting.
For detailed market insights: https://www.fortunebusinessinsights.com/industry-reports/digital-pathology-market-100229
Market Trends
Integration of Artificial Intelligence
The integration of Artificial Intelligence (AI) is one of the major trends shaping the digital pathology market. AI-based tools are increasingly being used for workflow management, image analysis, and assisted pathology. Companies are developing machine-learning and deep-learning solutions to meet the demand for advanced pathology technologies.
The source highlights several developments in this area. In December 2021, F. Hoffmann-La Roche Ltd. launched three AI-based digital pathology algorithms for deep-learning image analysis. In September 2023, Sigtuple received U.S. FDA approval for a blood smear application used in AI-assisted digital microscopy.
Growing Pathology Workflow Digitization
The increasing demand to digitize pathology workflows is encouraging companies to develop tools that streamline workloads and customize solutions. Strategic collaborations, product launches, and investments in AI-powered pathology platforms are further supporting this trend.
Market Drivers
Rising Burden of Chronic Diseases
The increasing incidence of chronic diseases is driving demand for pathology testing and, consequently, digital pathology products. A higher number of diagnostic tests increases the workload for pathologists, creating demand for digital tools that can improve workflow efficiency and support diagnostic activities.
Increasing Adoption of Digital Diagnostic Tools
Growing applications of digital pathology in disease diagnosis, predictive analysis, and drug discovery are supporting market expansion. Increasing regulatory approvals and government-funded research programs focused on digital pathology innovation are also expected to encourage adoption.
High-Throughput Applications
Digital pathology is increasingly being applied to drug discovery and high-throughput screening. The growing demand for potential pipeline drugs for life-threatening diseases is expected to make drug discovery one of the fastest-growing applications during the forecast period.
Market Restraint: High Upfront Costs
Despite strong growth prospects, high installation and training costs can restrict adoption. Digital pathology systems require scanners, analytical software, storage systems, technical support, training, and regulatory or licensing expenses. According to the source, digital pathology scanner list prices can range from USD 100,000 to USD 400,000, creating challenges for smaller and mid-sized laboratories.
Market Segmentation
The Digital Pathology Market is segmented by product, application, end-user, and geography.
By Product
The market is divided into hardware, software, and storage systems. Hardware dominated with a 58.10% share in 2026, supported by demand for timely pathology outcomes and increasing laboratory testing volumes. Hardware includes scanners, tissue microarrayers, and other products.
Software includes pathology management, digital microscopy viewers, image analyzers, and other solutions. Demand for AI-based algorithms and assisted analysis is supporting software growth. Storage systems are also gaining importance as laboratories need to store, access, share, and analyze digital pathology data.
By Application
Applications include disease diagnosis, drug discovery, and others. Disease diagnosis accounted for 54.96% of the market in 2026, driven by increasing pathology testing volumes and awareness of early diagnosis. Meanwhile, drug discovery is expected to record the highest CAGR during the forecast period.
By End-user
The market is categorized into hospitals & clinics, clinical laboratories, and others. Hospitals & clinics held the dominant position with a 62.18% share in 2026, supported by increasing patient admissions, pathology services, and adoption of digital tools.
Key Players
Major companies operating in the market include F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, and 3DHISTECH Ltd. These companies held significant market positions due to broad digital pathology portfolios, research and development investments, strategic collaborations, and established distribution channels.
Other companies profiled by Fortune Business Insights include Thermo Fisher Scientific Inc., Hamamatsu Photonics K.K., Apollo Enterprise Imaging Corp., Sectra AB, and Huron Technologies International Inc.
Regional Analysis
North America dominated the global market with a 36.74% share and USD 0.48 billion in revenue in 2025. The region is benefiting from chronic disease prevalence, an aging population, increasing pathology workloads, regulatory approvals, and partnerships aimed at developing innovative digital solutions. The North American market is expected to reach USD 0.54 billion in 2026.
Europe ranked second, accounting for 25.47% of the global market in 2025, with a value of USD 0.33 billion. Technological adoption, regulatory approvals, product launches, and developments in proprietary technologies are supporting regional growth.
Asia Pacific is expected to register the highest growth rate during the forecast period. The region accounted for 21.80% of the global market in 2025 and reached USD 0.28 billion. Increasing healthcare infrastructure, investments, patient populations, and partnerships are supporting adoption. Japan, China, and India are projected to reach USD 0.09 billion, USD 0.07 billion, and USD 0.05 billion, respectively, in 2026.
Latin America accounted for 8.66% of the market in 2025, while the Middle East & Africa held 7.33%. Growing digitization, medical tourism, remote case reviews, virtual education, and improved workflow are supporting growth in these regions.
Competitive Landscape
Competition in the digital pathology market is driven by technological innovation, product launches, partnerships, and AI development. Leading companies are focusing on customized platforms, advanced image analysis, and integrated digital workflows.
Recent developments include Roche's partnership with PathAI to develop AI digital pathology algorithms in February 2024, Roche's collaboration with Ibex and Amazon Web Services in October 2023, and PathAI's commercial launch of its AISight Digital Pathology Image Management System in August 2023.
Future Outlook
The digital pathology market is expected to maintain strong growth through 2034 as healthcare organizations increasingly adopt digital workflows. AI, machine learning, high-throughput algorithms, remote pathology, and advanced image analysis are expected to remain important areas of development.
The growing burden of chronic diseases and pathology testing will continue to create demand for efficient diagnostic technologies. At the same time, collaborations between technology companies, healthcare organizations, and pathology providers are expected to expand the availability of customized digital solutions. However, high equipment, training, storage, and integration costs may remain challenges, particularly for smaller laboratories.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pathology-market-100229
Conclusion
The Hot Digital Pathology Market is positioned for significant expansion as healthcare systems move toward more connected, efficient, and technology-enabled pathology workflows. With the market projected to increase from USD 1.47 billion in 2026 to USD 5.75 billion by 2034 at an 18.56% CAGR, opportunities are emerging across hardware, software, storage, diagnostics, and drug discovery. AI integration, rising chronic disease burdens, and workflow digitization are expected to remain key growth factors, while high upfront costs represent an important market challenge.
Latest 5 Trending FAQs
1. What is the global digital pathology market size?
According to Fortune Business Insights, the global digital pathology market was valued at USD 1.30 billion in 2025 and is projected to reach USD 5.75 billion by 2034.
2. What is the projected CAGR of the digital pathology market?
The market is expected to grow at a CAGR of 18.56% from 2026 to 2034.
3. Which segment leads the digital pathology market by product?
The hardware segment is projected to lead the market, holding a 58.10% share in 2026.
4. Which region dominates the digital pathology market?
North America dominated the global market with a 36.74% share in 2025, reaching USD 0.48 billion.
5. Who are the key players in the digital pathology market?
The leading players identified by Fortune Business Insights include F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, and 3DHISTECH Ltd.
What’s Driving Japan’s Market? Discover the Latest Digital Pathology Market Insights